Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 17.55M $681.46M Sept. 30, 2014
ClearBridge Advisors 8.24M $283.85M June 30, 2014
Artisan Partners Limited Partnership 7.37M $286.12M Sept. 30, 2014
Vanguard 7.26M $281.81M Sept. 30, 2014
BB Biotech AG 6.64M $257.70M Sept. 30, 2014
Waddell & Reed Financial 5.49M $213.34M Sept. 30, 2014
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
BlackRock Fund Advisors 4.12M $160.00M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 3.09M $119.92M Sept. 30, 2014
T. Rowe Price Associates 2.77M $95.30M June 30, 2014
STATE STREET CORPORATION 2.68M $103.93M Sept. 30, 2014
SUSQUEHANNA INTERNATIONAL 2.60M $100.91M Sept. 30, 2014
BVF 2.16M $25.94M June 30, 2012
LORD, ABBETT & CO 2.11M $56.65M June 30, 2013
Franklin Resources 2.08M $80.92M Sept. 30, 2014
Jennison Associates 2.03M $78.90M Sept. 30, 2014
Gail Mannix 1.94M $83.86M March 31, 2014
Tocqueville Asset Management 1.86M $64.18M June 30, 2014